Mechanism of human umbilical cord mesenchymal stem cells to promote platelet plasma coagulation

doi:10.12307/2022.407

Abstract

Abstract: BACKGROUND: With the in-depth study of clinical application of mesenchymal stem cell, the clinical use of mesenchymal stem cell has gradually changed. To enhance the role of mesenchymal stem cell in local tissues, stem cell is generally used in combination with local injection of gel, and autologous platelet-rich plasma is an ideal gel replacement material.
OBJECTIVE: To explore the mechanism of human umbilical cord mesenchymal stem cells to promote platelet plasma coagulation.
METHODS: (1) Stem cell was mixed with anticoagulated plasma. Calcium chloride was used to stimulate coagulation. Clotting time was recorded. The effect of the number of human umbilical cord mesenchymal stem cells on the clotting time of plasma was analyzed. (2) CD142 expression in stem cell was analyzed by flow cytometry. CD142 antibody was used to pretreat human umbilical cord mesenchymal stem cells and to ensure if CD142 was one of the most important factors to improve plasma coagulation. (3) CD142 expressing model and regulation model were analyzed by checking on database. WGCNA and text mining were used to achieve the result why CD142 gene expression level was high in human umbilical cord mesenchymal stem cells.
RESULTS AND CONCLUSION: (1) Platelet plasma coagulation could be accelerated by CD142 expression of human umbilical cord mesenchymal stem cells. CD142 expression was enhanced as the increase in mesenchymal stem cell passage. (2) CD142 upregulation was a result of mesenchymal stem cell autocrine. (3) CD142 could affect the ability of cell chemotaxis and colonization in human umbilical cord mesenchymal stem cells.

Key words: stem cells, mesenchymal stem cells, umbilical cord, platelet plasma, platelet-rich plasma, CD142, coagulation, plasma coagulation

CLC Number:

Liu Chao, Zhang Lijun, Du Xinjie, Xu Qian, Lü Hongjuan, Fan Dongmei, Tian Huanling, Huang Jian, Huang Yuxiang. Mechanism of human umbilical cord mesenchymal stem cells to promote platelet plasma coagulation[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(25): 4010-4015.

Figures/Tables 5

References

[1] LENG Z, ZHU R, HOU W, et al. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020;11(2):216-228.
[2] CHEN J, HU C, CHEN L, et al. Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment. Engineering (Beijing). 2020;6(10):1153-1161.
[3] GALIPEAU J, SENSÉBÉ L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018;22(6):824-833.
[4] BARBASH IM, CHOURAQUI P, BARON J, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108(7):863-868.
[5] JI SZ, XIAO SC, LUO PF, et al. An epidermal stem cells niche microenvironment created by engineered human amniotic membrane. Biomaterials. 2011;32(31):7801-7811.
[6] WANG X, JIANG B, SUN H, et al. Noninvasive application of mesenchymal stem cell spheres derived from hESC accelerates wound healing in a CXCL12-CXCR4 axis-dependent manner. Theranostics. 2019;9(21):6112-6128.
[7] JUNG HH, PARK K, HAN DK. Preparation of TGF-β1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells. J Control Release. 2010;147(1):84-91.
[8] SU J, DING L, CHENG J, et al. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum Reprod. 2016;31(5): 1075-1086.
[9] LI L, DUAN X, FAN Z, et al. Mesenchymal Stem Cells in Combination with Hyaluronic Acid for Articular Cartilage Defects. Sci Rep. 2018;8(1):9900.
[10] MARMOTTI A, ROSSI R, CASTOLDI F, et al. PRP and articular cartilage: a clinical update. Biomed Res Int. 2015;2015:542502.
[11] ABRAMS GD, FRANK RM, FORTIER LA, et al. Platelet-rich plasma for articular cartilage repair. Sports Med Arthrosc Rev. 2013;21(4):213-219.
[12] PAVLOVIC V, CIRIC M, JOVANOVIC V, et al. Platelet Rich Plasma: a short overview of certain bioactive components. Open Med (Wars). 2016;11(1):242-247.
[13] HERSANT B, SID-AHMED M, BRAUD L, et al. Platelet-Rich Plasma Improves the Wound Healing Potential of Mesenchymal Stem Cells through Paracrine and Metabolism Alterations. Stem Cells Int. 2019; 2019:1234263.
[14] 刘超,张丽君,陶昊,等.基于细胞生物学方法比较5种不同组织来源间充质干细胞的特征[J].中国组织工程研究,2019,23(33): 5334-5340.
[15] LANGFELDER P, HORVATH S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
[16] YU G, WANG LG, HAN Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-287.
[17] OTASEK D, MORRIS JH, BOUÇAS J, et al. Cytoscape Automation: empowering workflow-based network analysis. Genome Biol. 2019; 20(1):185.
[18] SCHENONE M, FURIE BC, FURIE B. The blood coagulation cascade. Curr Opin Hematol. 2004;11(4):272-277.
[19] MANN KG, KRUDYSZ-AMBLO J, BUTENAS S. Tissue factor controversies. Thromb Res. 2012;129 Suppl 2(Suppl 2):S5-7.
[20] SUN L, LIU Y, LIN S, et al. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor. Acta Oncol. 2013;52(4):842-851.
[21] MOHYELDIN A, GARZÓN-MUVDI T, QUIÑONES-HINOJOSA A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell. 2010;7(2):150-161.
[22] WIESE DM, RUTTAN CC, WOOD CA, et al. Accumulating Transcriptome Drift Precedes Cell Aging in Human Umbilical Cord-Derived Mesenchymal Stromal Cells Serially Cultured to Replicative Senescence. Stem Cells Transl Med. 2019;8(9):945-958.
[23] BEVILACQUA MP, POBER JS, MAJEAU GR, et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160(2):618-623.
[24] FOLCO EJ, MAWSON TL, VROMMAN A, et al. Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G. Arterioscler Thromb Vasc Biol. 2018;38(8):1901-1912.
[25] SASSA Y, HATA Y, MURATA T, et al. Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium. Graefes Arch Clin Exp Ophthalmol. 2002;240(12):1003-1010.
[26] FRIEDMAN R, BETANCUR M, BOISSEL L, et al. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant. 2007;13(12):1477-1486.
[27] 刘婷.脐带间充质干细胞体外扩增研究及其分泌细胞因子的高通量筛查[D].北京:中国人民解放军军事医学科学院, 2012.
[28] XU J, ZGHEIB C, HODGES MM, et al. Mesenchymal stem cells correct impaired diabetic wound healing by decreasing ECM proteolysis. Physiol Genomics. 2017;49(10):541-548.
[29] ALMALKI SG, AGRAWAL DK. Effects of matrix metalloproteinases on the fate of mesenchymal stem cells. Stem Cell Res Ther. 2016;7(1):129.
[30] TATSUMI K, OHASHI K, MATSUBARA Y, et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013;431(2):203-209.
[31] ANTEBI B, RODRIGUEZ LA 2ND, WALKER KP 3RD, et al. Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):265.
[32] REDONDO-CASTRO E, CUNNINGHAM CJ, MILLER J, et al. Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming. Stem Cell Res Ther. 2018; 9(1):11.
[33] TOBITA M, TAJIMA S, MIZUNO H. Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness. Stem Cell Res Ther. 2015;6:215.
[34] MISHRA A, TUMMALA P, KING A, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods. 2009;15(3):431-435.
[35] MOLL G, ANKRUM JA, KAMHIEH-MILZ J, et al. Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. Trends Mol Med. 2019;25(2):149-163.